Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
Concomitant use of rivaroxaban with non-dihydropyridine calcium channel blockers (non-DHPs) might lead to an increase of systemic rivaroxaban exposure and anticoagulant effects in relation to the inhibition of metabolic enzymes and/or transporters by non-DHPs. This study was designed to evaluate the...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2019-03-01
|
| Colección: | Pharmaceutics |
| Materias: | |
| Acceso en línea: | http://www.mdpi.com/1999-4923/11/3/133 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|